Schindler Rudolf

Person

Dresden, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrazoles
- Patent number RE49517
- Issue date May 2, 2023
- Janssen Pharmaceuticals, Inc.
- Rudolf Schindler
Information Patent Grant
Triazoles as NR2B receptor inhibitors
- Patent number 10,323,021
- Issue date Jun 18, 2019
- Janssen Pharmaceuticals, Inc.
- Rudolf Schindler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazoles
- Patent number 10,155,727
- Issue date Dec 18, 2018
- Janssen Pharmaceuticals, Inc.
- Rudolf Schindler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazoles as NR2B receptor inhibitors
- Patent number 9,981,950
- Issue date May 29, 2018
- Janssen Pharmaceuticals, Inc.
- Rudolf Schindler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
7-azaindoles and the use thereof as therapeutic agents
- Patent number 7,947,705
- Issue date May 24, 2011
- Biotie Therapies GmbH
- Norbert Höfgen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phos...
- Patent number 7,875,618
- Issue date Jan 25, 2011
- Wyeth
- Michael S. Malamas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesteras...
- Patent number 7,550,465
- Issue date Jun 23, 2009
- Elbion GmbH
- Norbert Höfgen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
7-azaindoles and the use thereof as therapeutic agents
- Patent number 7,211,583
- Issue date May 1, 2007
- Elbion AG
- Nobert Höfgen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,2,5-trisubstituted 1,2-dihydroindazol-3-ones having anti-asthmati...
- Patent number 6,180,637
- Issue date Jan 30, 2001
- Arzneimittelwerk Dresden GmbH
- Rudolf Schindler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, anti-a...
- Patent number 6,166,023
- Issue date Dec 26, 2000
- Arzneimittelwerk Dresden GmbH
- Rudolf Schindler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,3,5-tribsubstituted indazole derivatives, processes for preparing...
- Patent number 5,776,932
- Issue date Jul 7, 1998
- Arzneimittelwerk Dresden GmbH
- Rudolf Schindler
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRIAZOLES AS NR2B RECEPTOR INHIBITORS
- Publication number 20180282305
- Publication date Oct 4, 2018
- JANSSEN PHARMACEUTICALS, INC
- Rudolf Schindler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLES
- Publication number 20170275254
- Publication date Sep 28, 2017
- JANSSEN PHARMACEUTICALS, INC
- Rudolf Schindler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLES AS NR2B RECEPTOR INHIBITORS
- Publication number 20170226087
- Publication date Aug 10, 2017
- JANSSEN PHARMACEUTICALS, INC
- Rudolf Schindler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiestera...
- Publication number 20090239874
- Publication date Sep 24, 2009
- Norbert Hofgen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL AND HETEROARYL FUSED IMIDAZO[1,5-a]PYRAZINES AS INHIBITORS OF...
- Publication number 20090143367
- Publication date Jun 4, 2009
- ELBION GMBH
- Michael S. Malamas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of Treating Obesity and Metabolic Disorders
- Publication number 20090143392
- Publication date Jun 4, 2009
- ELBION GMBH
- Norbert Hofgen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors o...
- Publication number 20090143391
- Publication date Jun 4, 2009
- Norbert Hofgen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their U...
- Publication number 20090143361
- Publication date Jun 4, 2009
- ELBION GMBH
- Michael S. Malamas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesteras...
- Publication number 20080027064
- Publication date Jan 31, 2008
- Norbert Hofgen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHOD...
- Publication number 20070299079
- Publication date Dec 27, 2007
- Hofgen Norbert
- C07 - ORGANIC CHEMISTRY
Information Patent Application
7-Azaindoles and the use thereof as therapeutic agents
- Publication number 20070161671
- Publication date Jul 12, 2007
- Nobert Hofgen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
7-azaindoles and the use thereof as therapeutic agents
- Publication number 20040224971
- Publication date Nov 11, 2004
- Nobert Hofgen
- C07 - ORGANIC CHEMISTRY

Schindler Rudolf

Person

Patents Grantslast 30 patents

Pyrazoles

Triazoles as NR2B receptor inhibitors

Pyrazoles

Triazoles as NR2B receptor inhibitors

7-azaindoles and the use thereof as therapeutic agents

Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phos...

Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesteras...

7-azaindoles and the use thereof as therapeutic agents

1,2,5-trisubstituted 1,2-dihydroindazol-3-ones having anti-asthmati...

1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, anti-a...

1,3,5-tribsubstituted indazole derivatives, processes for preparing...

Patents Applicationslast 30 patents

TRIAZOLES AS NR2B RECEPTOR INHIBITORS

PYRAZOLES

TRIAZOLES AS NR2B RECEPTOR INHIBITORS

Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiestera...

ARYL AND HETEROARYL FUSED IMIDAZO[1,5-a]PYRAZINES AS INHIBITORS OF...

Methods of Treating Obesity and Metabolic Disorders

Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors o...

Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their U...

Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesteras...

4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHOD...

7-Azaindoles and the use thereof as therapeutic agents

7-azaindoles and the use thereof as therapeutic agents